Furthermore, as reported in another study, stabilization of TGFB2 mRNA levels by METTL14-mediated m6A modification and then knockdown of TGFB2 mRNA using shRNA found to lower TGFB2 expression decreased gemcitabine resistance in pancreatic cancer cells and increased cell apoptosis. This evidence concerns the gene TGFB2 and pancreatic neoplasm.